Comparison of the Treatment Efficacy of Suprascapular Nerve Block and Intraarticular Shoulder Injection Techniques in Patients Diagnosed With Adhesive Capsulitis

NCT06079515 | Completed

• 1 other identifier: 000000000000
• Study Type: interventional
• Target: 84
• Locations: 1 country
• Sites: 1

Brief Summary

Objective: We aim to compare the efficiency of the ultrasonography-guided suprascapular nerve block (SSNB) and ultrasonography-guided intra-articular shoulder injection (IAI) techniques in terms of pain and functional status in the treatment of adhesive capsulitis. Design: 60 patients with adhesive capsulitis were divided into two groups: SSNB and IAI. Both groups received an injection of 1 ml of 40 mg of triamcinolone acetonide and 9 ml of 0.5% bupivacaine hydrochloride. The patients' Shoulder Pain and Disability Index (SPADI) scores, shoulder active and passive range of motions (ROM), and visual analog scale (VAS) scores were evaluated before and after the injection in the 1st week, 4th week, and 12th week.

Conditions

Adhesive Capsulitis; Shoulder Pain

Keywords

adhesive capsulitis; suprascapular nerve blockade; intra-articular shoulder injection

Outcome Measures

Primary Outcomes (1)

• Shoulder Pain and Disability Index

  SPADI is a self-assessment scale with Turkish validity and reliability, consisting of two parts and a total of 13 questions; each question is scored between 0 and 10. Pain, disability, and total scores between 0 and 100 are obtained by calculating the percentage of the score indicated by the patients. SPADI variables were recorded as pain (SPADI-P), disability (SPADI-D), and total (SPADI-T) scores. Min score: 0 Max score: 100

  pre-injection, post-injection week 1, week 4, and week 12

Secondary Outcomes (2)

• Visual Analog Scale

  pre-injection, post-injection week 1, week 4, and week 12

• Shoulder Range of Motion

  pre-injection, post-injection week 1, week 4, and week 12

Study Arms (2)

Ali Akdağ

ACTIVE COMPARATOR

All injections were performed by him under the guidance of a Clarius portable USG device (L7 HD Linear Ultrasound Scanner). A total of 10 ml of a mixture of 1 ml of 40 mg triamcinolone acetonide (Kenakort-A ampoule) and 9 ml of 0.5% bupivacaine hydrochloride (Marcaine) was used in each injection.

Procedure: Suprascapular Nerve Block; Procedure: Intraarticular Shoulder Injection

Muhammet Hüseyin Sarı

EXPERIMENTAL

Blind observer to injections

Procedure: Suprascapular Nerve Block; Procedure: Intraarticular Shoulder Injection

Interventions

Suprascapular Nerve Block PROCEDURE

SSNB group: The patients were asked to sit comfortably in the chair, and the transducer was placed on the spine of the scapula in the coronal plane and moved laterally to observe the supraspinatus notch and the suprascapular nerve. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle on the suprascapular nerve, under the fascia of the supraspinatus muscle.

Ali Akdağ; Muhammet Hüseyin Sarı

Intraarticular Shoulder Injection PROCEDURE

IAI group: The patients were asked to sit on the chair with their hands facing the opposite shoulder, and the transducer was placed slightly below the spina scapula. The humeral head was observed by moving laterally. The injection mixture was applied in-plane with a 22-gauge, 90-mm needle entering the skin at a 45-degree angle and applied to the joint space

Ali Akdağ; Muhammet Hüseyin Sarı

Eligibility Criteria

• Age: 18 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Age between 15 to 75
• Adhesive phase

You may not qualify if:

• Patients with bilateral symptoms
• Radicular or inflammatory pain
• Uncontrolled DM
• Superficial infection at the injection site
• Bleeding disorder
• Stroke
• History of drug allergy
• Shoulder trauma in the last month
• Any steroid injection in the last 3 months
• Pregnant or postpartum patients
• Patients who had previously received shoulder physical therapy

Sponsors & Collaborators

• Antalya Training and Research Hospital: lead

Study Sites (1)

Antalya Education and Research Hospital

Antalya, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Bursitis; Shoulder Pain

Condition Hierarchy (Ancestors)

Joint Diseases; Musculoskeletal Diseases; Arthralgia; Pain; Neurologic Manifestations; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: INVESTIGATOR
• Masking Details: close envelope method
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER GOV
• Responsible Party: SPONSOR

Model Details: A total of 60 patients who met the criteria and agreed to participate in the trial were included in the study. The patients were randomized into two groups suprascapular nerve block (SSNB) and intra-articular injection (IAI) using the closed envelope method.

Study Record Dates

• First Submitted: September 8, 2023
• First Posted: October 12, 2023
• Study Start: March 1, 2022
• Primary Completion: October 1, 2022
• Study Completion: November 1, 2022
• Last Updated: October 12, 2023

Record last verified: 2023-09

Locations

TU (1)